The Melanoma Exposed strategy is simple: Screen – get routine skin cancer screenings and conduct self-exams; Protect your skin by limiting your exposure to UV rays year round; Know your risk factors, such as family history and number of moles; and most importantly, Tell others the facts about melanoma and encourage routine skin cancer screenings.
Now in its second year, the campaign continues to spread this message, and on
, it kicks off the first of several free public skin cancer screenings that will be held throughout the year with the Miami Dolphins, New York Giants, Denver Broncos, San Diego Chargers and Seattle Seahawks.
"When I learned about the
campaign last year, I made sure the whole team received a skin cancer screening as part of their annual physical, and we will continue these screenings for every player moving forward," said
, senior vice president for medical services for the New York Giants. "A skin cancer screening is an easy, painless procedure that may just be the most important 10 minutes of a person's life – especially men. I am glad the Giants and other teams are back in the game to support this important cause for a second year."
To learn more about these free skin cancer screenings, visit
Sponsored by the
campaign, the 2013
national survey was conducted to shed light on the barriers that keep men from getting screened for skin cancer. Key findings showed:
- Top reasons men avoid getting screened for skin cancer are: they simply don't have the time to get screened (42%), they think it's a woman's issue (31%) and they believe it's a waste of time (30%)
- Men would choose to do many activities before making a doctor's appointment if they had an extra 10 minutes, such as: chores (26%), napping (23%), snacking (22%) and checking their social networks (21%)
- 14% of men rank "skin screening" as one of the lowest priorities for doctor appointments, coming after an eye exam (39%), dental exam (35%) and blood test (29%)
"Last year, when we conducted skin cancer screenings at football games, many men did not want to get screened because they were afraid of what we might find, and our survey supports this sentiment," said
Elizabeth K. Hale
, M.D., clinical associate professor of dermatology at the
New York University
of School of Medicine. "Men don't get screened as often as they should, so we are catching it later when the cancer may have already progressed, which can be scary. Although I tend to see more women in my practice, I diagnose more men with the more aggressive stages of melanoma. The key with melanoma is to catch it early when it is most treatable."
To view the multimedia assets associated with this release, please visit:
Melanoma is a form of skin cancer that is caused by the overgrowth of a type of skin cell (melanocyte) that is responsible for producing the pigment melanin that gives color to the skin and eyes. The incidence of melanoma has been increasing for the past three decades; it is estimated that approximately 75,000 Americans are diagnosed annually with the disease.
Melanoma can occur anywhere on the body, but for men, it is most often found between the shoulders and hips or the head and neck. While the majority of melanomas occur on the skin, they can develop in other areas of the body where melanocytes exist, such as the mouth.
About the Melanoma Exposed Campaign
is a public awareness campaign designed to educate Americans about melanoma and its risk factors and encourage them to take a more active role in their skin health. The
campaign is a partnership of the following advocacy groups and is sponsored by Bristol-Myers Squibb. For more information about the campaign, visit
Melanoma International Foundation
Established in 2003, the Melanoma International Foundation (MIF) is a 501(c)(3) non-profit organization serving the community at large as a valuable resource. MIF develops, supports, and provides innovative programs for the prevention, early detection and treatment of melanoma as well as navigating patients to clinical trials where it hopes a viable treatment will be found.
Melanoma Research Alliance
The Melanoma Research Alliance (MRA) is a public charity formed under the auspices of the Milken Institute, with the generous founding support of
Debra and Leon Black
. It supports an international, cross-disciplinary group of biomedical researchers possessing clinical and scientific expertise to explore, identify and pursue innovative solutions to critical research questions, leading to better treatments and a cure for melanoma patients. Since its founding in 2007, MRA has become the largest private funder of melanoma research.
Melanoma Research Foundation
The Melanoma Research Foundation (MRF) is the largest independent organization devoted to melanoma. Committed to the support of medical research in finding effective treatments and eventually a cure for melanoma, the MRF also educates patients and physicians about prevention, diagnosis and the treatment of melanoma. The MRF is an active advocate for the melanoma community, helping to raise awareness of this disease and the need for a cure.
The Skin Cancer Foundation
The Skin Cancer Foundation is the only global organization solely devoted to the prevention, early detection and treatment of skin cancer. The mission of the Foundation is to decrease the incidence of skin cancer through public and professional education and research.
Bristol- Myers Squibb
is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit
, or follow the company on Twitter at
About the Survey and TNS
Participants in the 5-question, self-administered online omnibus survey were a nationally-representative sample of 1,250 American males 18 years of age and older. The study was conducted from
March 6, 2013
March 10, 2013
using the field services of TNS. The margin of sampling error at the 95% level of confidence is plus/minus 2.8%. Data are weighted to reflect accurate representation of the population.
TNS is the world's largest custom research agency delivering insights and research-based business advice to its clients so they can make more effective business decisions. TNS offers comprehensive industry knowledge within many different industry sectors, supported by a unique product offering that stretches across a range of marketing and business issues, specializing in product development and innovation, brand and communication, stakeholder management, retail and shopper, and qualitative research. TNS is part of the Kantar Group.